These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20223956)

  • 1. North Korea. New tuberculosis lab hailed as breakthrough in health diplomacy.
    Stone R
    Science; 2010 Mar; 327(5971):1312-3. PubMed ID: 20223956
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis in North Korea.
    Perry S; Linton H; Schoolnik G
    Science; 2011 Jan; 331(6015):263. PubMed ID: 21252318
    [No Abstract]   [Full Text] [Related]  

  • 3. Public enemy number one.
    Stone R
    Science; 2013 Apr; 340(6131):422-5. PubMed ID: 23620029
    [No Abstract]   [Full Text] [Related]  

  • 4. USA and North Korea work together on tuberculosis.
    Gee A
    Lancet; 2010 May; 375(9729):1862. PubMed ID: 20521344
    [No Abstract]   [Full Text] [Related]  

  • 5. Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
    Seung KJ; Franke M; Linton SW
    PLoS Med; 2016 Aug; 13(8):e1002062. PubMed ID: 27483430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North Korea and the Global Fund.
    Burki T
    Lancet Infect Dis; 2018 May; 18(5):501. PubMed ID: 29695364
    [No Abstract]   [Full Text] [Related]  

  • 7. North Korea's fight against tuberculosis gets a boost.
    Parry J
    BMJ; 2010 Apr; 340():c2223. PubMed ID: 20413565
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of primary drug resistance in M. tuberculosis in four administrative areas of the North-Western Federal District of the Russian Federation].
    Baranov AA; Mar'iandyshev AO; Nizovtseva NI; Oparina EN; Presnova SE; Gvozdovskaia LA; Markelov IuM; Trekin IA; Tungusova OS; Mannsoker T
    Probl Tuberk Bolezn Legk; 2006; (12):9-12. PubMed ID: 17300065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.
    Johansen IS; Larsen AR; Sandven P; Petrini B; Soini H; Levina K; Sosnovskaja A; Skenders G; Hoffner S
    Int J Tuberc Lung Dis; 2003 Sep; 7(9):899-902. PubMed ID: 12971676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growing problem of multidrug-resistant tuberculosis in North Korea.
    Seung KJ; Linton SW
    PLoS Med; 2013; 10(7):e1001486. PubMed ID: 23935457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 14. North Korea's health system in disarray.
    McCurry J
    Lancet; 2010 Jul; 376(9738):318. PubMed ID: 20681060
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China.
    Sugawara I; Otomo K; Yamada H; Wang G; Du C; Shi R; Zhang G
    Jpn J Infect Dis; 2005 Dec; 58(6):393-5. PubMed ID: 16377878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance and fitness in Mycobacterium tuberculosis infection.
    Bottger EC; Pletschette M; Andersson D
    J Infect Dis; 2005 Mar; 191(5):823-4; author reply 824. PubMed ID: 15688309
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of determination of drug resistance in Mycobacterium tuberculosis for successful treatment of pulmonary tuberculosis].
    Novozhilova IA
    Probl Tuberk Bolezn Legk; 2004; (4):29-31. PubMed ID: 15171041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.